Skip to main content

Animations

MJFF Publications

6921 - 6930 of 9033 Results
Title
Year
  • Year
  • 2014
  • 2020
  • 2021
  • 2022
  • 2019
  • 2020
  • 2023
  • 2023
  • 2016
  • 2025
  • The BioFIND Study (Fox Investigation For New Discovery Of Biomarkers In Parkinson’s Disease): Design And Methodology (P4.043)
    2014
    Summary Details
    RESTRICTED
    Title: The BioFIND Study (Fox Investigation For New Discovery Of Biomarkers In Parkinson’s Disease): Design And Methodology (P4.043)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.82.10_supplement.p4.043
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Remote Digital Monitoring for Medical Product Development
    Journal Name: Clinical and Translational Science
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1111/cts.12851
    Citation Count: 22
  • Summary Details
    OPEN
    Title: Systematic Assessment of 10 Biomarker Candidates Focusing on α‐Synuclein‐Related Disorders
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.28738
    Citation Count: 115
  • Summary Details
    OPEN
    Title: Impact of 100 LRRK2 variants linked to Parkinson's disease on kinase activity and microtubule binding
    Journal Name: Biochemical Journal
    Publisher: Portland Press Ltd.
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1042/bcj20220161
    Citation Count: 139
  • Summary Details
    OPEN
    Title: Motor phenotype classification in moderate to advanced PD in BioFIND study
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.06.017
    Citation Count: 29
  • Summary Details
    OPEN
    Title: The Most Bothersome Aspects of Off Periods Reported by Individuals with Parkinson's Disease
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mdc3.12915
    Citation Count: 20
  • Transdermal Nicotine Treatment and Progression of Early Parkinson’s Disease
    2023
    Summary Details
    RESTRICTED
    Title: Transdermal Nicotine Treatment and Progression of Early Parkinson’s Disease
    Journal Name: NEJM Evidence
    Publisher: Massachusetts Medical Society
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1056/evidoa2200311
    Citation Count: 25
  • Summary Details
    OPEN
    Title: Patterns of TDP‐43 Deposition in Brains with LRRK2 G2019S Mutations
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.29449
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.7554/elife.12813
    Citation Count: 1071
  • Summary Details
    OPEN
    Title: Longitudinal qualitative assessment of meaningful symptoms and relevance of WATCH-PD digital measures for people with early Parkinson’s
    Journal Name: Journal of Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00415-024-12789-0
    Citation Count: 12
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.